AbbVie cuts 2025 profit forecast on acquisition expenses - Reuters

Reuters | April 3, 2025, 4:48 p.m. | Original
AbbVie cuts 2025 profit forecast on acquisition expenses Reuters
US FDA approves Amgen's Uplizna as first treatment for rare immune disorder - Reuters Fed's Cook says time for patience on policy amid inflation risks - Reuters